Results 121 to 130 of about 50,472 (297)

Real‐World Survival Outcomes in EGFR‐Mutant Advanced NSCLC Treated With EGFR TKIs: Insights From a Single‐Center Clinical Data Warehouse Analysis in South Korea

open access: yesAsia-Pacific Journal of Clinical Oncology, Volume 22, Issue 3, Page 464-472, June 2026.
This retrospective cohort study was conducted using clinical data derived from a single‐center clinical data warehouse (CDW). In Korean patients with EGFR‐mutant advanced NSCLC, first‐line treatment with 3G EGFR TKIs (osimertinib or lazertinib) demonstrated significantly better overall survival than 1G or 2G agents.
Bomi Kim   +3 more
wiley   +1 more source

Performance Comparison of Knowledge-Based Dose Prediction Techniques Based on Limited Patient Data. [PDF]

open access: yes, 2018
PurposeThe accuracy of dose prediction is essential for knowledge-based planning and automated planning techniques. We compare the dose prediction accuracy of 3 prediction methods including statistical voxel dose learning, spectral regression, and ...
Landers, Angelia   +4 more
core  

Evaluation of Pulmonary Functions by Spirometry after Stereotactic Body Radiotherapy in Lung Tumors

open access: diamond, 2023
A. Giraldo Marín   +6 more
openalex   +2 more sources

Clinical implementation and evaluation of a patient‐specific surface‐guided clearance mapping system for collision avoidance and noncoplanar beam planning

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 5, May 2026.
Abstract Purpose/objectives Collision avoidance is critical in external beam radiotherapy to ensure patient safety and plan deliverability. Limited understanding of the collision‐free treatment space risks both patient safety and unnecessary exclusion of useful beams—particularly in noncoplanar setups—resulting in suboptimal plans. Conventional methods
Siqiu Wang   +10 more
wiley   +1 more source

Stereotactic body radiotherapy to the left lung in right lateral decubitus: A challenging case report

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 5, May 2026.
Abstract This case report describes a lung stereotactic body radiotherapy (SBRT) treatment complicated by the patient's inability to tolerate standard supine positioning, requiring simulation and delivery in the right lateral decubitus position. Five major workflow challenges were encountered involving patient positioning, 4DCT acquisition, treatment ...
Jochen Cammin   +4 more
wiley   +1 more source

Global research trends in radiotherapy for bone metastases: a systematic bibliometric analysis

open access: yesFrontiers in Oncology
BackgroundWith the development of various advanced radiotherapy techniques, research related to radiotherapy for bone metastases has made great progress, and scholars have published a large number of publications.
Fadong Yin   +7 more
doaj   +1 more source

Quality assurance program for prototype stereotactic system developed for Neptun 10 PC linac [PDF]

open access: yes, 2005
Background: A prototype stereotactic radiosurgery set was designed and constructed for a Neptun 10 PC linac that is currently being used at Imam Reza hospital in Mashhad.
Bahreyni Toosi, M.H.   +4 more
core  

COMP Report: Patient‐specific quality assurance practices in Canadian radiotherapy—results from a national survey

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 5, May 2026.
Abstract Patient‐specific quality assurance (PSQA) is an essential component of modern radiotherapy, ensuring safe and accurate delivery of increasingly complex treatments. Given its resource‐intensive nature and the availability of evolving approaches, examining how PSQA is implemented and optimized across Canada is important to inform best practices.
Muoi N. Tran   +7 more
wiley   +1 more source

Advancements in Glioblastoma Multiforme Treatment: A Comprehensive Systematic Review and Meta‐Analysis

open access: yesBrain and Behavior, Volume 16, Issue 5, May 2026.
This study is a systematic review and meta‐analysis comparing bevacizumab‐, temozolomide‐, and lomustine‐based treatments for recurrent glioblastoma. The findings suggest that monotherapy, particularly bevacizumab, may provide better clinical outcomes with fewer adverse events than combination regimens. ABSTRACT Background Glioblastoma multiforme (GBM)
Kayode Agboola   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy